Cargando…

Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease

Atrial natriuretic peptide (ANP) is a cardiac hormone with pleiotropic cardiovascular and metabolic properties including vasodilation, natriuresis and suppression of the renin-angiotensin-aldosterone system. Moreover, ANP induces lipolysis, lipid oxidation, adipocyte browning and ameliorates insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannone, Valentina, Cabassi, Aderville, Volpi, Riccardo, Burnett, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651335/ https://www.ncbi.nlm.nih.gov/pubmed/31269783 http://dx.doi.org/10.3390/ijms20133265

Ejemplares similares

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Posterior reversible encephalopathy syndrome in an oncological normotensive patient: evidence for a pathogenic role of concomitant low magnesium serum levels and chemotherapy treatment
por: Zappia, Federica, et al.
Publicado: (2020)

Natriuretic Peptides, Cardio-Oncology…
Publicado: (2023)

Natriuretic Peptides and Blood Pressure Homeostasis: Implications for MANP, a Novel Guanylyl Cyclase a Receptor Activator for Hypertension
por: Cannone, Valentina, et al.
Publicado: (2022)

Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism
por: Glöde, Anja, et al.
Publicado: (2017)

Innovative Therapeutics: Designer Natriuretic Peptides
por: Meems, Laura M.G., et al.
Publicado: (2016)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Altered Mitochondrial Metabolism and Mechanosensation in the Failing Heart: Focus on Intracellular Calcium Signaling
por: Cabassi, Aderville, et al.
Publicado: (2017)

The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population
por: Cannone, Valentina, et al.
Publicado: (2013)

Electrolyte Disorders Induced by Antineoplastic Drugs
por: Verzicco, Ignazio, et al.
Publicado: (2020)

Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide
por: Tokudome, Takeshi, et al.
Publicado: (2022)

EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM
por: Ma, Xiao, et al.
Publicado: (2023)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
por: Hinrichs, Lena, et al.
Publicado: (2020)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

Specific nutritional problems in acute kidney injury, treated with non-dialysis and dialytic modalities
por: Fiaccadori, Enrico, et al.
Publicado: (2010)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Atrial Natriuretic Peptide(31–67): A Novel Therapeutic Factor for Cardiovascular Diseases
por: da Silva, Gustavo Jose Justo, et al.
Publicado: (2021)

Case Report: Irreversible Watery Diarrhea, Severe Metabolic Acidosis, Hypokalemia and Achloridria Syndrome Related to Vasoactive Intestinal Peptide Secreting Malignant Pheochromocytoma
por: Negro, Aurelio, et al.
Publicado: (2021)

Natriuretic peptides: Diagnostic and therapeutic use
por: Pandit, Kaushik, et al.
Publicado: (2011)

Atrial natriuretic peptide and leptin interactions in healthy men
por: Daniels, Martin A., et al.
Publicado: (2023)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Mitochondrial mechanosensor in cardiovascular diseases
por: Caffarra Malvezzi, Cristina, et al.
Publicado: (2020)

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms
por: Gallo, Giovanna, et al.
Publicado: (2023)

The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases
por: Rubattu, Speranza, et al.
Publicado: (2018)

INDY as a Therapeutic Target for Cardio-Metabolic Disease
por: Pesta, Dominik, et al.
Publicado: (2022)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study)
por: Iorio, Annamario, et al.
Publicado: (2022)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease
por: Sato, Masafumi, et al.
Publicado: (2013)

Is Atrial Natriuretic Peptide (ANP) and Natriuretic Peptide Receptor-A (NPR-A) Expression in Human Placenta and Decidua Normal?
por: Tan, Hongchuan, et al.
Publicado: (2019)

Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats
por: Verzicco, Ignazio, et al.
Publicado: (2022)

Body cell mass evaluation in critically ill patients: killing two birds with one stone
por: Fiaccadori, Enrico, et al.
Publicado: (2014)

Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans
por: Birkenfeld, Andreas L., et al.
Publicado: (2008)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Atrial Natriuretic Peptide in Young and Elderly Children with Mild Gastroenteritis
por: Klar, A., et al.
Publicado: (2009)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dqahfose3hjmra95f0irhjfgio